GDS International Announces ‘Industry Leader of the Year” Award at its Fourth European Pharmac

PRLog (Press Release) - Dec. 4, 2012 - Europe has been an enduring force in the pharmaceutical industry for decades. However, increased competition due in part to globalisation, economic recession and ICT advancements has levelled the playing field for drug discovery. Wise investment and innovative new technologies are subsequently proving key to staying ahead of competitors. With this in mind, GDS International has created an award to recognise exceptional talent within the sector.

Selected as the winners by a panel of 20 senior executives from the R&D functions of global biopharma companies, Paul O’Riordan - CEO of Synexa Life Sciences, and Henning Steinhagen - SVP Head of Global Drug Discovery for Grünenthal, emerged the winners of this year’s 'Industry Leader of the Year' award for their pioneering new practices within the industry.

Synexa was awarded the title for their industry-leading approach to providing biopharma clients with biomarker expertise, analysis and insight; whilst Grünenthal was selected for their reorganization and strategy implementation for global chemistry outsourcing, and creating a new biology platform directed to immuno-inflammatory research.

Synexa's CEO, Paul O'Riordan, said: "This award is a tremendous acknowledgment of the hard work we have put in over the past ten years to develop a biomarker services offering that our clients find really useful. To be honoured in this way by the very clients we strive to satisfy is humbling and extremely rewarding. We will use this vote of confidence to continue pushing boundaries in both the science and business of biomarkers."

He continues: “I thought the conference was fantastic. I had some reservations, but the event well exceeded my expectations. The networking opportunities were invaluable - we met exactly the right people and a wide range of potential clients. These people seemed to really appreciate the opportunity to meet us too, which is not always the case at many conferences, and shows how well-selected they were.”

A massively successful event, the NG Pharmaceutical Drug Discovery summit continued its trend of attracting the region’s most renowned delegates and addressing the most pressing business challenges faced by executives in the industry today. Providing a stimulating contrast to the traditional event format, GDS International’s summits encourage discussion at a truly granular level.

The Next NG Pharmaceutical Drug Discovery Europe (http://www.pharmasummiteurope.com/) summit will be held next September 2013. There will be a range of Europe’s biggest drug discovery heavyweights joining the conversation, and a cutting edge programme in place to provide Next Generation solutions to next year’s common pain points.

For more information, please visit: www.pharmasummiteurope.com

About GDS International

GDS International (http://www.gdsinternational.com/) is one of the most innovative events and media companies worldwide – and a globally renowned producer of business-to-business summits, conferences, online information and advisory group gatherings. Founded in 1993, GDS International specialises in meeting the B2B marketing needs of our clients. Having a strong presence in mature industrial sectors but a finger on the pulse of emerging markets – as well as up-and-coming B2B business verticals – means we are perfectly placed to capitalise on the exciting developments brought about by the advent of a globalised economy. Our value proposition is simple: we deliver tangible business results from world-class events.

www.gdsinternational.com

Contact: Kimberley Hogarth

kimberley.hogarth@gdsinternational.com

0044 1179 261 420